NuvoCare responds to Canadian Tribunal Press Release

TORONTO, May 21, 2020 /CNW/ - According to Ryan J. Foley, President and CEO of Canadian based NuvoCare Health Sciences Inc. and i2 New ltd. out of Ireland, "NuvoCare stands behind all of the products we sell. NuvoCare is keen to work with the Commissioner and Competition Bureau to ensure that the representations it makes into the public do not raise issues under the Competition Act. We entered into a Temporary Consent Agreement with the Commissioner to provide you with time to have that discussion."

"The adequacy of the tests NuvoCare relies on is something that will form part of the broader conversation we will be having with the Commissioner and the Competition Bureau.  As I indicated, we are keen to work with the Competition Bureau to ensure that the representations the company makes do not raise issues under the Competition Act."

"We believe the tests we rely on are adequate and proper ? the Commissioner has taken a different view. We need to understand the Commissioner's perspective and, if appropriate, we are fully committed to making changes to our representations deemed incorrect."

NUVOCARE PROFILE:

Since 2006 NuvoCare Health Sciences Inc. has been manufacturing landmark nutritional supplement brands following three core principles:

1) EVIDENCE-BASED
2) CLINICAL STRENGTH DOSAGES
3) NATURALLY, BASED INGREDIENTS.

Our mission at NuvoCare is to be the most trusted name in Natural Health Products and Dietary Supplements.  "I make it my mission to design and manufacture products that make a difference in the lives of Canadians nationwide," says Ryan J Foley.

Ryan J Foley | President & CEO | NuvoCare Health Science Inc. | i2 New ltd.

SOURCE NuvoCare Health Sciences Inc.